Hyperacute rejection in ex vivo‐perfused porcine lungs transgenic for human complement regulatory proteins

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Transplant International

• Publication date

  2006-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2006.00267.xPMID 16441772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beyond antibody-mediated rejection: hyperacute lung rejection as a paradigm for dysregulated inflammation.

  2005cited by this paper
• Hyperacute Lung Rejection in the Pig-to-Human Model 4: Evidence for Complement and Antibody Independent Mechanisms

  2005influential reference
• Xenotransplantation: an update on recent progress and future perspectives

  2005cited by this paper
• Improved suppression of circulating complement does not block acute vascular rejection of pig‐to‐rhesus monkey cardiac transplants

  2004cited by this paper
• Pulmonary xenotransplantation: Rapidly progressing into the unknown

  2004cited by this paper
• Hyperacute lung rejection in the pig‐to‐human model. 2. Synergy between soluble and membrane complement inhibition

  2003influential reference
• Hyperacute lung rejection in the pig-to-human model. III. platelet receptor inhibitors synergistically modulate complement activation and lung injury

  2003cited by this paper
• Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.

  2003influential reference
• Perspectives on complement in xenotransplantation.

  2003cited by this paper
• Transgenic perspectives in xenotransplantation, 2001

  2002cited by this paper
• Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation.

  2002influential reference
• Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation.

  2002cited by this paper
• Protection of hDAF‐transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex

  2002cited by this paper
• Incidence of hyperacute rejection in pig-to-primate transplantation using organs from hDAF-transgenic donors

  2002cited by this paper
• CYTOMEGALOVIRUS EARLY PROMOTER INDUCED EXPRESSION OF hCD59 IN PORCINE ORGANS PROVIDES PROTECTION AGAINST HYPERACUTE REJECTION1

  2001cited by this paper
• C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

  2001cited by this paper
• Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection.

  2001influential reference
• Creation of long lasting luminescence in transparent aluminas

  2001cited by this paper
• Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation.

  2000cited by this paper
• The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants.

  2000cited by this paper
• Low-potassium dextran preservation solution improves lung function after human lung transplantation.

  2000cited by this paper
• C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model.

  1999cited by this paper
• Human complement regulatory proteins protect swine lungs from xenogeneic injury.

  1999cited by this paper
• Orthotopic heart transplantation in a transgenic pig-to-primate model.

  1998cited by this paper
• Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models.

  1998cited by this paper
• Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement.

  1997cited by this paper
• Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model.

  1997cited by this paper
• Characterization of pigs transgenic for human decay-accelerating factor.

  1997cited by this paper
• Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement.

  1997cited by this paper
• Ex vivo lung model of pig-to-human hyperacute xenograft rejection.

  1997cited by this paper
• Prolongation of cardiac xenograft survival by depletion of complement.

  1993cited by this paper
• The response of human platelets to activated components of the complement system.

  1991cited by this paper
• Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.

  1991cited by this paper

• Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target

  2023cites this paper
• C1-Inhibitor: Structure, Functional Diversity and Therapeutic Development.

  2021cites this paper
• Xenotransplantation: Where do we stand in 2016?

  2017cites this paper
• Expression of Human CD46 Modulates Inflammation Associated With GalTKO Lung Xenograft Injury

  2014cites this paper
• C1-Esterase-Inhibitor for Primary Graft Dysfunction in Lung Transplantation

  2014cites this paper
• Lung xenotransplantation: recent progress and current status

  2014cites this paper
• Bench-to-bedside review: The role of C1-esterase inhibitor in sepsis and other critical illnesses

  2011cites this paper
• Genetic modification of pigs for solid organ xenotransplantation.

  2011cites this paper
• Transgenic mice designed to express human α-1,2-fucosyltransferase in combination of human DAF and CD59 to avoid xenograft rejection

  2008cites this paper
• Progress and prospects: genetic engineering in xenotransplantation

  2008cites this paper
• Porcine Embryonic Stem Cells: A Possible Source for Cell Replacement Therapy

  2008cites this paper
• Biological activities of C1 inhibitor.

  2008cites this paper
• Current World Literature

  2007cites this paper
• Potential of an Injectable Polymer to Prevent Hyperacute Rejection of Ex Vivo Perfused Porcine Lungs

  2006cites this paper